Delivery Order SPE2DE21D7020-SPE2D625F0WSG
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,543.42 for the EMERGE MR 30MM product under the Defense Health Agency's Medical Supply Chain contract vehicle. This fixed-price delivery order with economic price adjustment features an ultimate completion date of August 4, 2025, and was issued on July 28, 2025. The award was made without set-aside restrictions, allowing Boston Scientific to...
- Boston Scientific Corp has been awarded a delivery order valued at $1,099.00 for EMERGE MR 12MM medical devices under a contract with the Defense Health Agency's Medical Supply Chain division. The award, issued on October 27, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and does not utilize a small business set-aside. Performance will be completed in Marlborough, Massachusetts, with an ultimate completion date of November 3, 2025. This delivery...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,341.85 by the Defense Health Agency's Medical Supply Chain on July 21, 2025. This fixed-price contract with economic price adjustment provisions is designated as contract number 4568850340 for NC EMERGE MR 20MM equipment, with an ultimate completion date of July 28, 2025. The award represents no set-aside designation, allowing Boston Scientific...
- The Defense Health Agency's Medical Supply Chain awarded a $4,995.90 delivery order to Boston Scientific Corp for NC EMERGE MR 8MM medical equipment on September 9, 2025, with an ultimate completion date of September 16, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company...
- Boston Scientific Corp has been awarded a delivery order (4569234767) valued at $3,129.62 by the Defense Health Agency's Medical Supply Chain for the supply of NC EMERGE MR 20MM medical devices. The contract, issued on August 27, 2025, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of September 4, 2025. Performance will be executed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was...
- Boston Scientific Corp has been awarded a delivery order valued at $1,660.29 by the Defense Health Agency's Medical Supply Chain on September 15, 2025, with an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment is designated as the NC EMERGE MR 15MM and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's headquarters in Marlborough,...
- Boston Scientific Corp has been awarded a delivery order valued at $2,545.15 under a fixed-price contract with economic price adjustment provisions by the Defense Health Agency's Medical Supply Chain office. The contract, designated as NC EMERGE MR 12MM, is scheduled for completion by March 31, 2025, with an award date of March 24, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents no set-aside designation, indicating...
- This is a federal contract award from the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $1,921.22, is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. The contract has an ultimate completion date of October 31, 2024. This award is not associated with any set-aside designation. Boston Scientific Corp will be providing the DHA with EMERGE MR 15MM medical...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $1,103.52 to Boston Scientific Corp on August 28, 2025, with an ultimate completion date of September 5, 2025. This fixed-price contract with economic price adjustment utilizes no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $1,444.32 to Boston Scientific Corp on June 2, 2025, with an ultimate completion date of June 9, 2025. This fixed-price delivery order with economic price adjustment utilizes no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The contract is performed at Boston Scientific's facility in Marlborough, Massachusetts, where the company manufactures and distributes...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0WSGDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $3,297 to Boston Scientific Corp on August 13, 2025, for the EMERGE MR 8MM product. The contract utilizes fixed-price pricing with economic price adjustment provisions and is set to conclude by August 20, 2025. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform this work at its facility in Marlborough, MA. No set-aside designation was applied to this award, allowing Boston Scientific to compete openly in the federal marketplace. This delivery order represents a continuation of Boston Scientific's substantial role as a critical supplier of advanced medical technologies to federal healthcare agencies. Boston Scientific's extensive portfolio with the Defense Health Agency and other federal healthcare entities demonstrates its established position as a trusted provider of specialized medical devices, including cardiovascular interventions, diagnostic equipment, and related medical technologies. The company maintains multiple indefinite delivery vehicles with federal agencies, including a $750,000 blanket purchase agreement with the Defense Health Agency for radiation treatment devices through March 30, 2030. This delivery order for the EMERGE MR 8MM product aligns with Boston Scientific's broader federal mission to supply cutting-edge medical technologies that support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/13/25 |